{
      "Rank": 384,
      "Acronym": [],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "Experimental: ALLO-ASC-DFU Hydrogel sheet containing allogenic adipose-derived mesenchymal stem cells",
            "Placebo Comparator: Vehicle Control Hydrogel sheet without allogenic adipose-derived mesenchymal stem cells"
      ],
      "ArmGroupInterventionName": [
            "Biological: ALLO-ASC-DFU",
            "Procedure: Hydrogel SHEET(Vehicle control)"
      ],
      "ArmGroupLabel": [
            "ALLO-ASC-DFU",
            "Hydrogel SHEET(Vehicle control)"
      ],
      "ArmGroupType": [
            "Experimental",
            "Placebo Comparator"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT03754465"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "This is a phase 2 double-blind clinical study to evaluate the efficacy and Safety of ALLO-ASC-SHEET in subjects with Diabetic Foot Ulcers, compared to placebo therapy."
      ],
      "BriefTitle": [
            "Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Foot Ulcers"
      ],
      "CentralContactEMail": [
            "armstrong@usa.net"
      ],
      "CentralContactName": [
            "David G. Armstrong, MD.Ph D."
      ],
      "CentralContactPhone": [
            "(+1)5203059393"
      ],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [
            "Contact"
      ],
      "CollaboratorClass": [],
      "CollaboratorName": [],
      "CompletionDate": [
            "December 30, 2022"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Diabetic Foot Ulcer"
      ],
      "ConditionAncestorId": [
            "D000010335",
            "D000003925",
            "D000014652",
            "D000002318",
            "D000007871",
            "D000012883",
            "D000012871",
            "D000048909",
            "D000003920",
            "D000004700",
            "D000003929",
            "D000005534"
      ],
      "ConditionAncestorTerm": [
            "Pathologic Processes",
            "Diabetic Angiopathies",
            "Vascular Diseases",
            "Cardiovascular Diseases",
            "Leg Ulcer",
            "Skin Ulcer",
            "Skin Diseases",
            "Diabetes Complications",
            "Diabetes Mellitus",
            "Endocrine System Diseases",
            "Diabetic Neuropathies",
            "Foot Diseases"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC14",
            "BC17",
            "BC19",
            "All",
            "BC23",
            "BC18",
            "BC10",
            "BC05"
      ],
      "ConditionBrowseBranchName": [
            "Heart and Blood Diseases",
            "Skin and Connective Tissue Diseases",
            "Gland and Hormone Related Diseases",
            "All Conditions",
            "Symptoms and General Pathology",
            "Nutritional and Metabolic Diseases",
            "Nervous System Diseases",
            "Musculoskeletal Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Diabetic Foot",
            "Foot Ulcers",
            "Ulcer"
      ],
      "ConditionBrowseLeafId": [
            "M19085",
            "M18071",
            "M16358",
            "M6272",
            "M16552",
            "M10035",
            "M14838",
            "M14826",
            "M6267",
            "M25157",
            "M7014",
            "M6276",
            "M7810"
      ],
      "ConditionBrowseLeafName": [
            "Diabetic Foot",
            "Foot Ulcer",
            "Ulcer",
            "Diabetic Angiopathies",
            "Vascular Diseases",
            "Leg Ulcer",
            "Skin Ulcer",
            "Skin Diseases",
            "Diabetes Mellitus",
            "Diabetes Complications",
            "Endocrine System Diseases",
            "Diabetic Neuropathies",
            "Foot Diseases"
      ],
      "ConditionBrowseLeafRelevance": [
            "high",
            "high",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000017719",
            "D000016523",
            "D000014456"
      ],
      "ConditionMeshTerm": [
            "Diabetic Foot",
            "Foot Ulcer",
            "Ulcer"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Randomized"
      ],
      "DesignInterventionModel": [
            "Parallel Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "Double"
      ],
      "DesignMaskingDescription": [
            "Double-Blind"
      ],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [
            "Participant",
            "Investigator"
      ],
      "DetailedDescription": [
            "Active Group: ALLO-ASC-SHEET\nControl Group: Hydrogel SHEET (vehicle control)\nStudy Type: Interventional\nStudy Design: Randomized, Comparator-controlled, Double-blind, multi-center study."
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nMale or female subjects between 18 and 80 years of age.\nDiagnosed with Type I or Type II diabetics and has diabetic foot ulcers for longer than 4 weeks at the screening visit.\nFoot ulcer located in the instep, border or sole of the foot, with ulcer size between 1 cm2 and 15 cm2.\nUlcer graded I by Wagner grade, and extended to skin, subcutaneous tissue, but without exposure of muscle, tendon, bone or joint capsule.\nUlcer is free of necrotic debris, exhibits no signs of clinical infection.\n\nUlcer area blood circulation meets one of the following criteria\n\nA. Blood vessels around the ulcer detected by Doppler Test\nB. range of Ankle Brachial Index(ABI) was > 0.7 to < 1.3\nC. Transcutaneous oxygen pressure, (TcPO2) > 30 mmHg.\nIs able to give written informed consent prior to study start and to comply with the study requirements.\n\nExclusion Criteria:\n\nUlcer is of non-diabetic pathophysiology.\nThe ulcer has increased or decreased in size by \u2265 30% during the week after the Screening Visit.\nIs Human Immunodeficiency Virus (HIV) positive?\nHave severe hepatic deficiencies.\nHave a glycated hemoglobin A1c (HbA1c) level of > 10%.\nHave allergic or hypersensitive reaction to bovine-derived proteins or fibrin glue.\nRequire intravenous (IV) antibiotics to treat the target wound infection.\nHave severe renal failure including subject on renal dialysis.\nPregnant or breast-feeding.\nIs unwilling to use an \"effective\" method of contraception during the study.\nHave evidence of current infection including pus drainage from the wound site.\nHave a clinically relevant history of alcohol or drugs abuse.\nHave postprandial blood sugar > 350 mg/dl.\nIs not able to understand the objective of this study or to comply with the study requirements.\nIs considered by the investigator to have a significant disease which might have impacted the study.\nIs considered not suitable for the study by investigator.\nHave a history of malignancy within the last five years (except basal cell carcinoam in situ).\nIs currently or were enrolled in another clinical study within 60 days of screening.\nHave undergone wound treatments with growth factors, dermal substitutes, or other biological therapies within the last 30 days.\nIs receiving oral or parenteral corticosteroids, immunosuppressive, or cytotoxic agents with unstable dose prior to 4 weeks from screening.\nCannot maintain off-loading process\nPanel reactive antibody (PRA) levels \u2265 20%"
      ],
      "EnrollmentCount": [
            "56"
      ],
      "EnrollmentType": [
            "Anticipated"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [
            "No"
      ],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "ALLO-ASC-DFU",
            "Hydrogel SHEET(Vehicle control)"
      ],
      "InterventionBrowseBranchAbbrev": [],
      "InterventionBrowseBranchName": [],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [],
      "InterventionBrowseLeafName": [],
      "InterventionBrowseLeafRelevance": [],
      "InterventionDescription": [
            "Application of ALLO-ASC-DFU Sheet to diabetic foot ulcer",
            "Application of Hydrogel SHEET to diabetic foot ulcer"
      ],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "ALLO-ASC-DFU",
            "Hydrogel SHEET(Vehicle control)"
      ],
      "InterventionOtherName": [
            "Hydrogel sheet containing Allogenic Mesenchymal Stem Cells",
            "Hydrogel sheet without Allogenic Mesenchymal Stem Cells"
      ],
      "InterventionType": [
            "Biological",
            "Procedure"
      ],
      "IsFDARegulatedDevice": [
            "No"
      ],
      "IsFDARegulatedDrug": [
            "Yes"
      ],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [],
      "LastUpdatePostDate": [
            "May 3, 2022"
      ],
      "LastUpdatePostDateType": [
            "Actual"
      ],
      "LastUpdateSubmitDate": [
            "May 2, 2022"
      ],
      "LeadSponsorClass": [
            "INDUSTRY"
      ],
      "LeadSponsorName": [
            "Anterogen Co., Ltd."
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Los Angeles"
      ],
      "LocationContactEMail": [],
      "LocationContactName": [
            "David G. Armstrong, MD.Ph D."
      ],
      "LocationContactPhone": [],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [
            "Contact"
      ],
      "LocationCountry": [
            "United States"
      ],
      "LocationFacility": [
            "University of Southern California"
      ],
      "LocationState": [
            "California"
      ],
      "LocationStatus": [
            "Recruiting"
      ],
      "LocationZip": [
            "90089"
      ],
      "MaximumAge": [
            "80 Years"
      ],
      "MinimumAge": [
            "18 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "A Phase 2 Clinical Study to Evaluate the Efficacy and Safety of ALLO-ASC-SHEET in Subjects With Diabetic Foot Ulcers"
      ],
      "OrgClass": [
            "INDUSTRY"
      ],
      "OrgFullName": [
            "Anterogen Co., Ltd."
      ],
      "OrgStudyId": [
            "ALLO-ASC-SHEET-102"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "University of Southern California",
            "Center for Clinical Research",
            "Martinsville Research Institute"
      ],
      "OverallOfficialName": [
            "David G. Armstrong, MD.Ph D.",
            "Alexander M. Reyzelman, DPM",
            "Young Nathan, DPM"
      ],
      "OverallOfficialRole": [
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator"
      ],
      "OverallStatus": [
            "Recruiting"
      ],
      "OversightHasDMC": [
            "Yes"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 2"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "December 30, 2022"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [
            "Proportions of subjects who achieved complete wound closure"
      ],
      "PrimaryOutcomeMeasure": [
            "Proportions of subjects who achieved complete wound closure"
      ],
      "PrimaryOutcomeTimeFrame": [
            "During 12 weeks"
      ],
      "ReferenceCitation": [],
      "ReferencePMID": [],
      "ReferenceType": [],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [],
      "ResponsiblePartyInvestigatorFullName": [],
      "ResponsiblePartyInvestigatorTitle": [],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [
            "Time to initial complete wound closure between the two groups",
            "Wound size is measured by using eKare 3D Wound Measurement system(Mobile Devices)",
            "Proportions of subjects who achieved complete wound closure",
            "Wound size is measured by using eKare 3D Wound Measurement system(Mobile Devices)"
      ],
      "SecondaryOutcomeMeasure": [
            "Time to initial complete wound closure between the two groups",
            "Changes in wound size compared to baseline between the two groups",
            "Proportions of subjects who achieved complete wound closure by the classification of location of diabetic foot ulcer, Plantar and the other location between the two groups",
            "Durability of complete wound closure"
      ],
      "SecondaryOutcomeTimeFrame": [
            "During 12 weeks",
            "During 12 weeks",
            "During 12 weeks(at every visit during treatment period)",
            "Follow up to 24 weeks from the initial complete wound closure."
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "January 2, 2019"
      ],
      "StartDateType": [
            "Actual"
      ],
      "StatusVerifiedDate": [
            "April 2022"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "November 27, 2018"
      ],
      "StudyFirstPostDateType": [
            "Actual"
      ],
      "StudyFirstSubmitDate": [
            "November 20, 2018"
      ],
      "StudyFirstSubmitQCDate": [
            "November 25, 2018"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": []
}